1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
No deadline on page; informational program landing page.
AIM-AHEAD Program is sponsored by National Institutes of Health (NIH). NIH's AIM-AHEAD program establishes mutually beneficial and coordinated partnerships to empower researchers and communities in the development of AI/ML models and enhance the capabilities of this emerging technology, beginning with electronic health record (EHR) data.
The program aims to integrate AI/ML-focused, data science research networks with community engagement and clinical research networks.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
AIM-AHEAD | Data Science at NIH NIH’s AIM-AHEAD program will establish mutually beneficial and coordinated partnerships to empower researchers and communities across the United States in the development of AI/ML models and enhance the capabilities of this emerging technology, beginning with electronic health record (EHR) data.
The rapid increase in the volume of data generated through electronic health records (EHRs) and other biomedical research presents exciting opportunities for developing data science approaches, such as AI/ML methods, to enhance biomedical research and improve healthcare.
Several challenges hinder the widespread adoption of AI/ML technologies, including high costs, limited capability for broad application, and inadequate access to necessary infrastructure, resources, and training.
Additionally, there is a lack of comprehensive and high-quality AI-ready data, as well as a shortage of a pipeline of talented researchers in both industry and academia, to harness the potential of AI/ML in advancing biomedical research and the practice of medicine. Furthermore, tackling the complex drivers of health outcomes require an innovative and transdisciplinary framework that transcends scientific and organizational silos.
Mutually beneficial and trusted partnerships can be established to empower researchers and communities across the United States in AI/ML application. Recognizing these challenges and leveraging the potential of AI/ML to accelerate the pace of biomedical innovation, the NIH launched AIM-AHEAD in July 2021.
The AIM-HEAD is a nationwide network of institutions and organizations designed to build AI talent among researchers and clinicians, support multidisciplinary research projects that harness AI/ML to improve the health of Americans and enhance the AI capabilities and infrastructure of limited-resourced communities or hospitals that otherwise would not have had the resources or the capacity to benefit from the advance of AI/ML.
AIM-AHEAD focuses on four key areas to drive this mission: AIM-AHEAD will create a “network of networks” through regional, multi-disciplinary partnerships. The goal is to integrate AI/ML-focused, data science research networks with community engagement and clinical research networks to form mutually beneficial collaborations and to engage scientists across the career pipeline.
AIM-AHEAD’s multi-disciplinary partners will use new, real world data or synthetic, and existing datasets, such as EHR, image data, and non-traditional data; develop and enhance AI/ML algorithms; and apply AI/ML approaches to to improve health for all Americans. This work may encompass improved healthcare, prevention, diagnoses, and treatments and facilitate intervention and implementation strategies.
AIM-AHEAD will enable a coordinated data and computing infrastructure that enhances the interoperability of large-scale data resources with data that are maintained, governed, and prepared by individual institutions to preserve privacy and autonomy.
AIM-AHEAD will implement training opportunities in data science and health research, large scale data management, cloud computing, and other areas to increase capabilities in AI/ML analytics. Learn more about how AIM-AHEAD was developed. View the original concept clearance report and slides presented at the May 6, 2021, meeting of the Advisory Committee to the NIH Director .
--> To learn more about the AIM-AHEAD program, visit https://aim-ahead. net . AIM-AHEAD impact, broad outreach, and support of awardees and complex projects in many different domains across the nation.
Please direct questions about AIM-AHEAD to [email protected] (link sends e-mail) . This page last reviewed on This page last reviewed on May 2, 2022
According to the current listing, eligibility includes: Researchers and communities across the United States. Confirm the full requirements in the official notice before applying.
AIM-AHEAD Program is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
NOT-OD-26-120 moved the DMS Plan elimination for NIH Career Development awards from October 12, 2027 to effective immediately. Active, pending, and future K applicants are all covered. Here is what changed, what did not, and where the paperwork will lag the policy.
Read articleNIH is carrying its emergency peer review modifications into the January 2027 Advisory Council with more than 35,000 applications in the queue. Discussion drops to 30-35 percent, the middle third becomes "competitive but not discussed" and stays eligible for funding, and the resume of discussion disappears from your summary statement. Here is what each change does to a real application.
Read articleNOT-OD-26-100 took effect October 1, 2026: no more prior approval to modify an approved DMS Plan, no more eRA Commons request type, and one annual RPPR field now carrying the entire record. Here is what that trade actually costs.
Read article